# Comparison of 12-day Reverse Hybrid Therapy and 12-day Standard Triple Therapy for Helicobacter Pylori Infection

> **NCT02359435** · NA · COMPLETED · sponsor: **Kaohsiung Veterans General Hospital.** · enrollment: 440 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Reverse hybrid therapy
- **DRUG:** Standard triple therapy

## Key facts

- **NCT ID:** NCT02359435
- **Lead sponsor:** Kaohsiung Veterans General Hospital.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 440 (ACTUAL)
- **Last updated:** 2017-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02359435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02359435, "Comparison of 12-day Reverse Hybrid Therapy and 12-day Standard Triple Therapy for Helicobacter Pylori Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02359435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*